Antibiotico-resistenza e antibiotico-sensibilità: bibliografia per breakpoint MIC

Elenco dei riferimenti bibliografici dei break point applicati per l’interpretazione dei dati delle MIC in Istituto Zooprofilattico Sperimentale delle Venezie.

Ultimo aggiornamento: 20 dicembre 2019.

Abbreviazione sul rapporto di prova Riferimento bibliografico
Aarestrup et al., 2002 Aarestrup FM., Butaye P., Witte W. 2002. Nonhuman Reservoirs of Enterococci. In “The Enterococci: Pathogenesis, Molecular Biology, and Antibiotic Resistance”. Edited by S. Gilmore et al., ASM Press, Washingthon DC, 20036, 2904.
Bakum Break point adottati presso il Laboratorio Diagnostico Veterinario di Bakum, Università di Hannover, Germania.
Beheraham et al., 2008 Behbahan NGG, Asaki K, Afsharifar AR, Pourbakhsh SA.  Susceptibilities of Mycoplasma gallisepticum and Mycoplasma synoviae isolates to antimicrobial agents in vitro. Int J Poul Sci. 2008;7(11): 1058-1064.
CA-SFM Break point suggeriti dalla Società Francese di Microbiologia in ambito veterinario. https://www.sfm-microbiologie.org/wp-content/uploads/2019/01/CASFM_VET2018.pdf
CA-SFM/EUCAST Break points suggeriti in umana da lla Società Francese di Microbiologia e approvati da EUCAST. https://www.sfm-microbiologie.org/wp-content/uploads/2019/02/CASFM2019_V1.0.pdf
CLSI, 2008 Clinical and Laboratory Standards Institute. Methods for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria isolated from animals. 1st ed. CLSI document VET 06. Wayne, PA: Clinical and Laboratory Standards Institute; 2017.
CLSI, 2008 Clinical and Laboratory Standards Insistute (CLSI), 2008. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals: Approved Standard, In: CLSI Document M31-A3. Clinical and Laboratory Standards Institute, Wayne, PA, USA.
CLSI-H Break point per microrganismi isolati dall’uomo presenti nel manuale CLSI M100 S23, 2013.
CLSI-V Manuale CLSI VET01-S2 – Performan standards for antimicrobial disk and dilution susceptibility tests for Bacteria isolated from animals
CLSI-V HD Break point applicati in umana e suggeriti per microrganismi animali nel Manuale CLSI VET01-S2i. Performan standards for antimicrobial disk and dilution susceptibility tests for Bacteria isolated from animals
CLSI-V HD on line Break applicati in umana e suggeriti per microrganismi animali nel Manuale CLSI VET08, ED4:2018. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals, 4th Edition. http://vet01s.edaptivedocs.info/dashboard.aspx
CLSI-V on line Manuale CLSI VET08, ED4:2018. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals, 4th Edition. http://vet01s.edaptivedocs.info/dashboard.aspx
CLSI-VF Manuale CLSI VET06 – Method for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria isolated from animals
CLSI-VF HD Break point applicati in umana e suggeriti per microrganismi animali nel Manuale CLSI VET06 – Method for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria isolated from animals
De Jong et al., 2014 De Jong,A.,Thomas,V.,Simjee,S.,Moyaert,H.,ElGarch,F.,&Maher,K.(2014). Antimicrobial susceptibility monitoring of respiratory tract pathogens isolated from diseased cattle and pigs across Europe: The VetPath study. Veterinary Microbiology, 172(1–2), 202–215. https://doi.org/10.1016/J.VETMIC.2014.04.008
ECOFF IZSTv/dati IZS-Tv Break point epidemiologici individuati attraverso studi di antimicrobico-sensibilità condotti presso la Sezione di Treviso.
EUCAST Break point sugegriti da EUCAST. https://mic.eucast.org
EUCAST ECOFF Break point epidemiologici suggeriti da EUCAST. https://mic.eucast.org
FEBLER 2012 Feßler A.T., Kaspar H., Lindeman C.J., Stegemann M.R., Peters T., Mankertz J., Watts J.L., Schwarz S. .2012.A proposal of interpretive criteria for cefoperazone applicable to bovine mastitis pathogens. Veterinary Microbiology 157 (2012) 226–231.
Gautier-Bouchardon, 2000 Gautier-Bouchardon AV1, Reinhardt AK, Kobisch M, Kempf I. In vitro development of resistance to enrofloxacin, erythromycin, tylosin, tiamulin and oxytetracycline in Mycoplasma gallisepticum, Mycoplasma iowae and Mycoplasma synoviae. Vet Microbiol. 2002 Aug 2;88(1):47-58.
Hannan et al., 1997 Hannan PCT, Windsor GD, de Jong A, Schmeer N, Stegemann H. Comparative susceptibilities of various animal-pathogenic mycoplasmas to fluoroquinolones. Antimicrob Agents Chemoter. 1997;41: 2037-2040.
Kempf et al., 1989 Kempf I, Ollivier C, Guittet M, Morin Y, Bennejean G. Efficacité de la spiramycine et de la tylosine pour la prévention de la mycoplasmose chez des poussins expérimentalement infectés par Mycoplasma gallisepticum [Efficacy of spiramycin and tylosin in preventing mycoplasmosis in chicks experimentally infected with mycoplasma gallisepticum]. Pathol Biol (Paris). 1989;37(5 Pt 2):560–564.
LAM Simjee S., Amedeo J., Barletta A.M., Pridmore A. 2011. Use of Tylan 200 for the treatment of Mastitis caused by Staphylococcus aureus and/or Streptococcus uberis. In Udder health and communication – Ed. Hogaveen, Lam.
Pedersen K. et al., 2007 Karl Pedersen, Kristina Pedersen, Helene Jensen, Kai Finster, Vibeke F. Jensen, Ole E. Heuer; Occurrence of antimicrobial resistance in bacteria from diagnostic samples from dogs, Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, 1 October 2007, Pages 775–781, https://doi.org/10.1093/jac/dkm269
Pringle et al., 2012 Antimicrobial susceptibility of porcine Brachyspira hyodysenteriae and Brachyspira pilosicoli isolated in Sweden between 1990 and 2010
Ronne H. and Szancher J., 1990 Rønne, H., Szancer, J., 1990. Proceedings of the International PigVeterinary Society Congress, Lausanne, Switzerland. p. 126
Santos et al., 2010 Santos, T. M. A., L. S. Caixeta, V. S. Machado, A. K. Rauf, R. O. Gilbert, and R. C. Bicalho. 2010a. Antimicrobial resistance and presence of virulence factor genes in Arcanobacterium pyogenes isolated from the uterus of postpartum dairy cows. Vet. Microbiol. 145:84–8
Ter Laak et al., 1991 Ter Laak EA, Pijpers A, Noordergraaf JH, Schoevers EC, Verheijden JH. Comparison of methods for in vitro testing of susceptibility of porcine Mycoplasma species to antimicrobial agents. Antimicrob Agents Chemother. 1991;35(2):228–233. doi:10.1128/aac.35.2.228
USDA Break point suggeriti da USDA. https://www.ars.usda.gov/ARSUserFiles/60400520/NARMS/ABXEntero.pdf
Wang et al., 2008 Wang Y., Wu C.M., Lu L. M., Na Ren G.W., Cao X.Y., Shen J.Z. 2008. Macrolide–lincosamide-resistant phenotypes and genotypes of Staphylococcus aureus isolated from bovine clinical mastitis. Vet. Mic., 130 (1–2):118-125.
Wisselink et al., 2006 Wisselink,H.J., Veldman, K.T., Van den Eede, C., Salmon, S.A., Mevius, D.J., 2006.Quantitative susceptibility of Streptococcus suis strains isolated from diseased pigs inseven European countries to antimicrobial agents licensed in veterinary medicine.Vet. Microbiol. 113, 73–82.